News und Analysen
![Will cost cuts be enough for Hasbro to thrive in 2024?: https://www.marketbeat.com/logos/articles/med_20231231120706_chartt-has.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOEwvYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--643eaa486c7823ac019996fb876ec3780f705bc4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231231120706_chartt-has.jpg?locale=de)
Will cost cuts be enough for Hasbro to thrive in 2024?
Global toy and entertainment company Hasbro Inc. (NYSE: HAS) had a weak 2023 as shares fell 17.5% compared to the 24.8% gain for the S&P 500 index. It also underperformed rival Mattel Inc. (NYSE:
![Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205: https://www.irw-press.at/prcom/images/messages/2024/73150/Aktiencheck030124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMXovYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2168a3cbb5338b13f96a4403747baf1bd91ec4f6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Aktiencheck030124.001.png?locale=de)
Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205
Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Kaufsignal. 297% Biotech Aktientip nach 15.973% mit BioNTech
03.01.24
London (www.aktiencheck.de, Anzeige)
Link
![Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205: https://www.irw-press.at/prcom/images/messages/2024/73150/Aktiencheck030124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMXovYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2168a3cbb5338b13f96a4403747baf1bd91ec4f6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Aktiencheck030124.001.png?locale=de)
Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205
Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Kaufsignal. 297% Biotech Aktientip nach 15.973% mit BioNTech
03.01.24
London (www.aktiencheck.de, Anzeige)
Link
![Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205: https://www.irw-press.at/prcom/images/messages/2024/73150/Aktiencheck030124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMXovYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2168a3cbb5338b13f96a4403747baf1bd91ec4f6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Aktiencheck030124.001.png?locale=de)
Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205
Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Kaufsignal. 297% Biotech Aktientip nach 15.973% mit BioNTech
03.01.24
London (www.aktiencheck.de, Anzeige)
Link
![Analysts suddenly say Google is the place to be in: https://www.marketbeat.com/logos/articles/med_20240102074605_analysts-suddenly-say-google-is-the-place-to-be-in.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBKy8rYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1083dd04e50802d7c4ee68190fa6f0e3a85beb80/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240102074605_analysts-suddenly-say-google-is-the-place-to-be-in.jpg?locale=de)
Analysts suddenly say Google is the place to be in
Very few times in history have investors come across a stock that offers the sort of moat that Warren Buffett could salivate over, a strong business with solid financials and a structure
![Analysts suddenly say Google is the place to be in: https://www.marketbeat.com/logos/articles/med_20240102074605_analysts-suddenly-say-google-is-the-place-to-be-in.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBKy8rYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1083dd04e50802d7c4ee68190fa6f0e3a85beb80/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240102074605_analysts-suddenly-say-google-is-the-place-to-be-in.jpg?locale=de)
Analysts suddenly say Google is the place to be in
Very few times in history have investors come across a stock that offers the sort of moat that Warren Buffett could salivate over, a strong business with solid financials and a structure
![Analysts suddenly say Google is the place to be in: https://www.marketbeat.com/logos/articles/med_20240102074605_analysts-suddenly-say-google-is-the-place-to-be-in.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBKy8rYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1083dd04e50802d7c4ee68190fa6f0e3a85beb80/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240102074605_analysts-suddenly-say-google-is-the-place-to-be-in.jpg?locale=de)
Analysts suddenly say Google is the place to be in
Very few times in history have investors come across a stock that offers the sort of moat that Warren Buffett could salivate over, a strong business with solid financials and a structure
![One fast-food stock is expected to outperform all others in 2024: https://www.marketbeat.com/logos/articles/med_20240102074256_one-fast-food-stock-is-expected-to-outperform-all.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOC8rYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3beba95070d9728db8eeac40a7830153fe911810/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240102074256_one-fast-food-stock-is-expected-to-outperform-all.jpg?locale=de)
One fast-food stock is expected to outperform all others in 2024
With a 20% rally under its belt since October, it goes without saying that McDonald's Corp (NYSE: MCD) is coming into 2024 looking pretty hot. After a disappointing Q3 threatened to spiral out of
![One fast-food stock is expected to outperform all others in 2024: https://www.marketbeat.com/logos/articles/med_20240102074256_one-fast-food-stock-is-expected-to-outperform-all.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOC8rYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3beba95070d9728db8eeac40a7830153fe911810/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240102074256_one-fast-food-stock-is-expected-to-outperform-all.jpg?locale=de)
One fast-food stock is expected to outperform all others in 2024
With a 20% rally under its belt since October, it goes without saying that McDonald's Corp (NYSE: MCD) is coming into 2024 looking pretty hot. After a disappointing Q3 threatened to spiral out of
![2 fast-casual restaurants to grab before they get taken out: https://www.marketbeat.com/logos/articles/med_20231231122144_chart-sg2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOUgrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e41cb2f8abe1f801ff6e65440195bcb055a428fd/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231231122144_chart-sg2.jpg?locale=de)
2 fast-casual restaurants to grab before they get taken out
The fast-casual dining segment is part of the consumer discretionary sector. The segment is no stranger to acquisitions and mergers. Restaurants that have grown to become iconic fixtures, having
![PepsiCo's dividend won't last long in today's market: https://www.marketbeat.com/logos/articles/med_20240101143450_pepsicos-dividend-wont-last-long-in-todays-market.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOUQrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1daf898bb8bad1a7a4ebe78b0ad2be44e752c0af/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240101143450_pepsicos-dividend-wont-last-long-in-todays-market.jpg?locale=de)
PepsiCo's dividend won't last long in today's market
Markets shift according to a straightforward selection process; as money becomes interested in better instruments or investments, money as a whole begins to rotate into different areas of the
![PepsiCo's dividend won't last long in today's market: https://www.marketbeat.com/logos/articles/med_20240101143450_pepsicos-dividend-wont-last-long-in-todays-market.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOUQrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1daf898bb8bad1a7a4ebe78b0ad2be44e752c0af/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240101143450_pepsicos-dividend-wont-last-long-in-todays-market.jpg?locale=de)
PepsiCo's dividend won't last long in today's market
Markets shift according to a straightforward selection process; as money becomes interested in better instruments or investments, money as a whole begins to rotate into different areas of the
![ConAgra is still a value investor’s dream: https://www.marketbeat.com/logos/articles/med_20231231120927_chart2-cag.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlQrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--fa43221c8d8e0331b18ecb03d82e1d759443f4b5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231231120927_chart2-cag.jpg?locale=de)
ConAgra is still a value investor’s dream
Packaged and frozen foods maker ConAgra Brands Inc. (NYSE: CAG) had a rough 2023, with shares losing 26.19% versus the S&P 500 index performance of 24.8%. The weak macroeconomic environment led to
![2 gene-editing stocks reshaping hereditary disease treatments: https://www.marketbeat.com/logos/articles/med_20231231121858_chart-ntla.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNkgrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d8cf7f26c4d9caf0889b2db456211e7f76836263/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231231121858_chart-ntla.jpg?locale=de)
2 gene-editing stocks reshaping hereditary disease treatments
Gene-editing companies are making headlines for the potential to reshape the future of healthcare and the treatment of hereditary diseases. The U.S. Federal Drug Administration (FDA) approved a
![4 reasons to buy Dutch Bros stock over Starbucks: https://www.marketbeat.com/logos/articles/med_20231231121354_chart-bros2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNkwrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e1c9cebf72a0f4cd55b634899a8cefacfc3137e9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231231121354_chart-bros2.jpg?locale=de)
4 reasons to buy Dutch Bros stock over Starbucks
Drive-thru coffee and beverage operator Dutch Bros Inc. (NASDAQ: BROS) stock has more upside than the incumbent behemoth Starbucks Co. (NASDAQ: SBUX) on a percentage basis. Its newly minted CEO
![4 reasons to buy Dutch Bros stock over Starbucks: https://www.marketbeat.com/logos/articles/med_20231231121354_chart-bros2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNkwrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e1c9cebf72a0f4cd55b634899a8cefacfc3137e9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231231121354_chart-bros2.jpg?locale=de)
4 reasons to buy Dutch Bros stock over Starbucks
Drive-thru coffee and beverage operator Dutch Bros Inc. (NASDAQ: BROS) stock has more upside than the incumbent behemoth Starbucks Co. (NASDAQ: SBUX) on a percentage basis. Its newly minted CEO
![4 reasons to buy Dutch Bros stock over Starbucks: https://www.marketbeat.com/logos/articles/med_20231231121354_chart-bros2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNkwrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e1c9cebf72a0f4cd55b634899a8cefacfc3137e9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231231121354_chart-bros2.jpg?locale=de)
4 reasons to buy Dutch Bros stock over Starbucks
Drive-thru coffee and beverage operator Dutch Bros Inc. (NASDAQ: BROS) stock has more upside than the incumbent behemoth Starbucks Co. (NASDAQ: SBUX) on a percentage basis. Its newly minted CEO
![New price targets could erase Cisco's 3.1% dividend yield soon: https://www.marketbeat.com/logos/articles/med_20240101140630_new-price-targets-could-erase-ciscos-3.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlArYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--07115fedf8efcf6ca8433a73204d56cd8122aa88/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240101140630_new-price-targets-could-erase-ciscos-3.jpg?locale=de)
New price targets could erase Cisco's 3.1% dividend yield soon
A new FED has come into play to end 2023 with a major surprise for most investors out there trying to find a direction to bet on and the implications this new view has are plenty, but today, you
![New price targets could erase Cisco's 3.1% dividend yield soon: https://www.marketbeat.com/logos/articles/med_20240101140630_new-price-targets-could-erase-ciscos-3.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlArYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--07115fedf8efcf6ca8433a73204d56cd8122aa88/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240101140630_new-price-targets-could-erase-ciscos-3.jpg?locale=de)
New price targets could erase Cisco's 3.1% dividend yield soon
A new FED has come into play to end 2023 with a major surprise for most investors out there trying to find a direction to bet on and the implications this new view has are plenty, but today, you
![New price targets could erase Cisco's 3.1% dividend yield soon: https://www.marketbeat.com/logos/articles/med_20240101140630_new-price-targets-could-erase-ciscos-3.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlArYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--07115fedf8efcf6ca8433a73204d56cd8122aa88/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240101140630_new-price-targets-could-erase-ciscos-3.jpg?locale=de)
New price targets could erase Cisco's 3.1% dividend yield soon
A new FED has come into play to end 2023 with a major surprise for most investors out there trying to find a direction to bet on and the implications this new view has are plenty, but today, you
![New price targets could erase Cisco's 3.1% dividend yield soon: https://www.marketbeat.com/logos/articles/med_20240101140630_new-price-targets-could-erase-ciscos-3.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlArYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--07115fedf8efcf6ca8433a73204d56cd8122aa88/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240101140630_new-price-targets-could-erase-ciscos-3.jpg?locale=de)
New price targets could erase Cisco's 3.1% dividend yield soon
A new FED has come into play to end 2023 with a major surprise for most investors out there trying to find a direction to bet on and the implications this new view has are plenty, but today, you
![Weight Watchers gains from Oprah’s GLP-1 weight-loss: https://www.marketbeat.com/logos/articles/med_20231231120220_charttt-ww.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlgrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f0cf2e0099df6c1be6a4cb0728f7267b9b86fc20/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231231120220_charttt-ww.jpg?locale=de)
Weight Watchers gains from Oprah’s GLP-1 weight-loss
Oprah Winfrey revealed she has lost over 60 pounds and is on the path to reaching her weight goal of 167 lbs. She credits this to taking GLP-1 medication and WW International Inc. (NYSE: WW)
![Is the Apple Watch ban the tipping point?: https://www.marketbeat.com/logos/articles/med_20231231120446_chartt-aapl.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMEQrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--162e404cc31f7fcd12195d79f259e53280c66c80/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231231120446_chartt-aapl.jpg?locale=de)
Is the Apple Watch ban the tipping point?
Apple Inc. (NYSE: AAPL) had a stellar 2023, gaining 49.39% for 2023 while maintaining the largest weighting in the S&P 500. While the technology sector juggernaut continues to grow, its sales have
![Is the Apple Watch ban the tipping point?: https://www.marketbeat.com/logos/articles/med_20231231120446_chartt-aapl.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMEQrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--162e404cc31f7fcd12195d79f259e53280c66c80/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231231120446_chartt-aapl.jpg?locale=de)
Is the Apple Watch ban the tipping point?
Apple Inc. (NYSE: AAPL) had a stellar 2023, gaining 49.39% for 2023 while maintaining the largest weighting in the S&P 500. While the technology sector juggernaut continues to grow, its sales have
![Is the Apple Watch ban the tipping point?: https://www.marketbeat.com/logos/articles/med_20231231120446_chartt-aapl.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMEQrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--162e404cc31f7fcd12195d79f259e53280c66c80/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231231120446_chartt-aapl.jpg?locale=de)
Is the Apple Watch ban the tipping point?
Apple Inc. (NYSE: AAPL) had a stellar 2023, gaining 49.39% for 2023 while maintaining the largest weighting in the S&P 500. While the technology sector juggernaut continues to grow, its sales have